SPRO: FDA approval, immunology pivot, and $105M financing extend cash runway into 2029
SPRO: FDA approval, immunology pivot, and $105M financing extend cash runway into 2029 TradingView
Finance, IT & News
SPRO: FDA approval, immunology pivot, and $105M financing extend cash runway into 2029 TradingView
Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight BioSpace
FDA Approves Centanafadine for ADHD Physician's Weekly
FDA approves new Lasik treatment now available at Minnesota clinic CBS News
FDA clears Wandercraft’s Eve exoskeleton for wheelchair users MobiHealthNews